Role of Pharmaceutical Care in Type 2 Diabetic Patients in Kirkuk City
DOI:
https://doi.org/10.32947/ajps.v20i4.788Abstract
Background and objectives. Diabetes Mellitus is a chronic metabolic disorder that negatively affects patient’s quality of life and creates a huge burden on both patients and health care system. Effective pharmaceutical intervention could result in a tighter disease control,
reducing long term complications and improving the quality of life.
Methods: In this study, a prospective clinical trial was performed to evaluate the role of pharmaceutical care in reducing complications and in improving the quality of life among patients with T2DM.A total of 189 patients were included and divided into two groups; the first group: consisted of 95 patients, comprised the intervention group who received regular pharmaceutical care on monthly basis. The rest 94 patients were allocated to the non-intervention group who only received usual medical care. Patient selection was carried out according to certain inclusion and exclusion criteria. Two categories of data were recorded from each participant at 6 time points during the study period. The first category was assessment of risk factors of complication such as hypertension, hyperlipidemia, uncontrolled hyperglycemia, physical inactivity and smoking. The second category was current status of diet and quality of life.
Results: The number of drug therapy problems non-adherence to medication and HBA1c were significantly reduced and quality of life was significantly improved among intervention group. Other Clinical and blood parameters were not affected.
Conclusion: Pharmacist collaboration with physicians regarding management of type II diabetes patients have yielded a better patient management outcome, reduced risk factors and improved the quality of life in those patients.
References
- Idf.org. IDF MENA region, 2019.
- Powers AC. Diabetes mellitus: diagnosis, classification, and pathophysiology.In: Harrison’s Principles of Internal Medicine. 19th ed. United States of America: McGraw-Hill; 2015. p. 2399–407.
- Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a metaanalysis.Arch. Intern. Med. 169(19), 17481–17755 (2009). DOI: https://doi.org/10.1001/archinternmed.2009.316
- WHO? New tool to enhance role of pharmacists in health care. 2006.
- Mohamad Adam Bujang, Tassha Hilda Adnan, NurKhairu lBariyyah Mohd Hatta,Mastura Ismail, and ChienJoo Lim. A Revised Version of Diabetes Quality of Life InstrumentMaintaining Domains for Satisfaction, Impact, and Worry. Journal of Diabetes Research Volume 2018, Article ID 5804687, 10 pages https://doi.org/10.1155/2018/5804687 DOI: https://doi.org/10.1155/2018/5804687
- Pharmaceutical Society of Australia. Standard and guidelines forpharmacists performing clinical interventions. March 2011.
- Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with Type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am. J. Manag.Care 11(4), 2532–2560 (2005).
- Leal S, Glover JJ, Herrier RN, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care 27(12), 29832–29984 (2004). DOI: https://doi.org/10.2337/diacare.27.12.2983
- Yohanes Ayele, KibkabMelaku, MesayDechasa, Mohammed Biset Ayalew and Boressa Adugna Horsa.Assessment of drug related problems among type 2 diabetes mellitus patients with hypertension in HiwotFana Specialized University Hospital, Harar, Eastern Ethiopia. Ayele et al. BMC Res Notes (2018) 11:728 DOI: https://doi.org/10.1186/s13104-018-3838-z
- Sabine Ruths, Kirsten K. Viktil and Hege Salvesen Blix. Classification of drug-related problems. TidsskrNorLægeforen 2007; 127: 3073–6
- Hasniza Zaman Huri1 and Lee Chai Ling. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health 2013, 13:1192 DOI: https://doi.org/10.1186/1471-2458-13-1192
- Wrood Salim Al-Khfajy, AmaniAneesAboddy,InamSamehArif. Diabetic Patients' Adherence to Medications and Related Factors in a Sample of The Iraqi Population. Proceedings of 177th The IIER International Conference, Istanbul, Turkey, 20th-21st July, 2018
- Suppapitiporn S, Chindavijak B, Onsanit S. Effect of Diabetes drug counseling bypharmacist, Diabetes disease booklet and special medication containers on glycemiccontrol of type 2 Diabetes mellitus: A randomized controlled trial. Journal of theMedical Association of Thailand 2005; 88 (4): S134 – 41.
- Jennifer BRB, Guimaraes VG, Mesquita AR, Aguiar PM, Krass I, Pereira DL. Enhancinghealth care for type 2 Diabetes in Northern Brazil: A pilot study of pharmaceutical carein community pharmacy. African Journal of Pharmacy and Pharmacology 2012; 6 (35):2584-2591 DOI: https://doi.org/10.5897/AJPP12.51
- Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-270. DOI: https://doi.org/10.1001/jama.282.3.267
Downloads
Published
How to Cite
Issue
Section
License
